EUVIMEDEUVIMED entdecken
Crossref

Dihydroartemisinin-Piperaquine Based Post Discharge Malaria Chemoprevention Improved Parasite Clearance and Haemoglobin Recovery in Children

Preye D. Ogbe, Peter P. Erigbali

SIAR-Global Journal of Medicine & Pharmaceutical Review · 10.11.2026 · Issue 3, Oct.-Dec. (Vol. 2) · 20

DOI: 10.66694/siar.gjmpr20263003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SIAR-Global Journal of Medicine & Pharmaceutical Review, online erschienen am 10.11.2026. Verfasst von Preye D. Ogbe und 1 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe malarial anaemia (SMA) remains a leading cause of paediatric hospitalisation and mortality in sub-Saharan Africa, particularly in high-transmission settings such as Nigeria's Niger Delta region. This study evaluated the clinical efficacy of dihydroartemisinin–piperaquine (DHA PQ) in children with severe malarial anaemia;, by assessing parasite clearance and haemoglobin recovery. A prospective, randomized, open-label comparative study was conducted involving 108 children aged 6–59 months with SMA recruited from Niger Delta University Teaching Hospital and Bayelsa State Specialist Hospital. After completing standard treatment intravenous artesunate followed by an oral artemisinin-based combination therapy (ACT)], participants were randomly allocated to receive either four 3-day courses of DHA-PQ, with the first course administered at discharge and subsequent courses during weeks 2–3, 6–7 and 10–11 after discharge (12 doses in total over approximately 3 months; verify the dosing schedule and number of doses per course) (n=71), or a placebo comparator of paracetamol and vitamin C as the control regimen on the same schedule (control, n=37). Outcomes measured included parasite clearance and haemoglobin recovery. Baseline characteristics Baseline characteristics showed profound anaemia (mean haemoglobin 3.8 ± 0.5 g/dL), high parasite density (60,864 ± 8,096 parasites/μL), and significant nutritional heterogeneity. DHA-PQ demonstrated superior parasite clearance, with parasite density falling to 113 ± 93 parasites/μL after the third dose of week 6-7, third course (compared to 1,245 ± 866 parasites/μL in the control group (p < 0.001). Haemoglobin recovery was significantly greater in the DHA-PQ group (7.1 ± 0.8 g/dL vs 6.2 ± 0.9 g/dL; p < 0.001). Logistic regression identified DHA-PQ treatment (AOR = 3.84, p = 0.008), parasite density (AOR = 0.62, p < 0.001), and haemoglobin (AOR = 1.56, p = 0.002). Children who received DHA-PQ had 3.84 times the adjusted odds of treatment success compared with children who did not receive DHA PQ. Since the 95% CI (1.42-10.37) does not include 1 and the association was statistically significant (p = 0.008), DHA-PQ treatment was therefore a significant positive predictor of treatment success. DHA-PQ was well tolerated, and was associated with faster parasite clearance, and greater haemoglobin recovery.

Zitieren

APA

Ogbe, P. D., & Erigbali, P. P. (2026). Dihydroartemisinin-Piperaquine Based Post Discharge Malaria Chemoprevention Improved Parasite Clearance and Haemoglobin Recovery in Children. SIAR-Global Journal of Medicine & Pharmaceutical Review, Issue 3, Oct.-Dec.(Vol. 2), 20. https://doi.org/10.66694/siar.gjmpr20263003

Vancouver

Ogbe PD, Erigbali PP. Dihydroartemisinin-Piperaquine Based Post Discharge Malaria Chemoprevention Improved Parasite Clearance and Haemoglobin Recovery in Children. SIAR-Global Journal of Medicine & Pharmaceutical Review. 2026;Issue 3, Oct.-Dec.(Vol. 2):20. doi:10.66694/siar.gjmpr20263003

BibTeX
@article{Ogbe2026,
  author = {Ogbe, Preye D. and Erigbali, Peter P.},
  title = {Dihydroartemisinin-Piperaquine Based Post Discharge Malaria Chemoprevention Improved Parasite Clearance and Haemoglobin Recovery in Children},
  journal = {SIAR-Global Journal of Medicine & Pharmaceutical Review},
  year = {2026},
  volume = {Issue 3, Oct.-Dec.},
  number = {Vol. 2},
  pages = {20},
  doi = {10.66694/siar.gjmpr20263003}
}
Kostenlos starten →